Skip to content

The clinical study on pulse acupuncture for treating TP/TC chemotherapy-induced alopecia of patients with gynecologic cancers

The clinical study on pulse acupuncture for treating TP/TC chemotherapy-induced alopecia of patients with gynecologic cancers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067388
Enrollment
Unknown
Registered
2023-01-06
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced alopecia

Interventions

Group 1:routine acupuncture
Group 2:pulse acupuncture
Group 3:comprehensive nursing intervention

Sponsors

Guangdong Hospital of Traditional Chinese Medicine University City Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Gynecological malignant tumors diagnosed by clinicopathology, including ovarian cancer, endometrial cancer, and cervical cancer; 2. Receive postoperative adjuvant chemotherapy or palliative chemotherapy for the first time; 3. Completed all TP (paclitaxel + cisplatin) or TC (paclitaxel + carboplatin) chemotherapy courses (4-8 courses); 4. According to Dean's Hair Loss Scale, subjectively evaluate the degree of hair loss >= 2 grades; 5. No medical history related to obvious hair loss; 6. The general condition is good, and the Karnofsky score is greater than or equal to 60 points; 7. The expected survival period is more than 3 months; 8. Female patients aged between 18 and 70 years; 9. Patients who agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have suffered from hair loss diseases in the past; or are now accompanied by related diseases such as hair loss and alopecia areata, making it difficult to determine the curative effect; 2. Patients with severe organ dysfunction, such as heart, kidney and liver failure; 3. Coma, confusion, restlessness, abnormal movement, dementia, mental retardation, no independent judgment and extreme weakness; 4. Patients who have brain metastases during the treatment and need head radiotherapy; 5. Obvious blood coagulation dysfunction and skin infection and other diseases, affecting acupuncture treatment.

Design outcomes

Primary

MeasureTime frame
Grading of toxic effects on the severity of hair loss in World Health Organisation (WHO)Handbook for reporting results of cancer treatment;

Secondary

MeasureTime frame
Hair growth rate;Condition of hair growth ;Karnofsky Performance Status (KPS) Scale;Chemotherapy-induced Alopecia Distress Scale (CADS);quality of life index;

Countries

China

Contacts

Public ContactXiao Jing

Guangdong Hospital of Traditional Chinese Medicine University City Hospital

xiaojingson_2004@126.com+86 135 5614 8318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026